Incivo Articles
Australia to subsidize groundbreaking hepatitis C drugs under PBS
19 February 2013
First interferon-free regimens for hepatitis C virus expected to launch in 2014 in the USA and Europe
20 December 2012
Incivo plus peginterferon and ribavirin positive for co-infected hep C and HIV patients, says Janssen
12 November 2012
Germany’s IQWiG sees added benefits for Incivo
24 January 2012
Johnson & Johnson’s telaprevir approved in Europe for genotype-1 chronic hepatitis C
21 September 2011
Europe’s CHMP adopts positive opinions on Dexdor, Incivo, Plenadren, Vyndaqel and Zytiga; backs extensions
23 July 2011
Showing 1-8 of 8 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
